1100 13th Street, NW, Suite 750Washington, DC 20005202.887.6400Customer Service: 800.544.0155
All Contents © 2019The Kiplinger Washington Editors
Biotech stocks often present intriguing, and potentially very lucrative, investment opportunities. Share prices can explode on positive trial results or key regulatory approvals.
That big, scary downturn at the end of 2018 may be in the rearview mirror, but that doesn't mean you can just forget it. Here are six steps investors can take to be ready for the next time.
Stock buybacks crashed through the ceiling in 2018. Companies in the Standard & Poor’s 500-stock index alone announced plans to repurchase almost $1 trillion in shares – a tactic that not only makes...
More Investing News »